Biotech सार्वजनिक
[search 0]
अधिक
Download the App!
show episodes
 
Biotech—it's complicated. A successful product launch requires grit, determination, and clear direction. But let’s be real, the path to launch isn’t a straight one. There are curves, hard turns, and dead ends. Here’s the good news, you don’t have to navigate the complexities alone. Welcome to The Emerging Biotech Leader, where we help biotech leaders maximize the value of their therapeutics from clinical development to product launch.
  continue reading
 
Artwork

1
Grow Everything Biotech Podcast

Messaginglab

Unsubscribe
Unsubscribe
साप्ताहिक
 
Grow Everything brings to life the bioeconomy when hosts Karl Schmieder and Erum Azeez Khan share stories from the field and interview leaders and influencers in the space. Life is a powerful force and it can be engineered. What will we create? Learn more at www.messaginglab.com/groweverything Topics: synthetic biology, entrepreneurship, policy, community, education, biotech, life sciences
  continue reading
 
Artwork

1
Pharma and BioTech Daily

Pharma and BioTech News

Unsubscribe
Unsubscribe
साप्ताहिक+
 
This podcast aims to bring you a daily summary of most relevant news in Pharma and BioTech world, fully automated and Generated by ChatGPT. If you're interested in similar podcast checkout www.owith.ai
  continue reading
 
Artwork

1
Inside Biotech

Ananta Wadhwa, Kathy Grotsch PhD, Gabriella Rubert, Leo Ying

Unsubscribe
Unsubscribe
मासिक
 
Inside Biotech is an exciting podcast from BCLA, which focuses on the science behind SoCal’s most innovative new biotech companies. This semi-monthly podcast, hosted by Gabriella Rubert, Ph.D. Candidate at UCLA and Podcast Lead at BCLA, is the perfect way for anyone interested in LA’s biotech community to stay informed about current progress and developments. Episodes feature conversations with scientists, entrepreneurs, investors, and more about the cutting-edge science that goes on inside ...
  continue reading
 
Artwork
 
Welcome to BIOTECH NATION !!! With understandable interviews requiring no background in science, BTN attracts a wide global audience. From everyday people looking for hope in treatments in development, to bioentrepreneurs interested in the experience of their fellow travelers, to venture capitalists looking for possibilities in cutting-edge breakthroughs, to scientists simply interested in the work of others, BioTech Nation is the voice of human endeavor, driving science to new realities for ...
  continue reading
 
Welcome to the official Labiotech.eu podcast - Beyond Biotech! Each week, we talk about what's happening in the world of biotech, with news and interviews with experts from companies around the world. Join us as we cover the latest news, breakthroughs and innovations shaping the life sciences industry.A new podcast episode is available every Friday.The host is Jim Cornall.
  continue reading
 
Welcome to The Biotech Startups Podcast by Excedr. Join us as we speak with first-time founders, experienced scientists, long-time company operators, serial entrepreneurs, and biotech investors about the challenges and triumphs of running a biotech startup. Gain actionable insight into navigating the ever-changing life sciences industry in each episode as we explore the business of science, from pre-seed to IPO. With your host, Jon Chee.
  continue reading
 
Artwork

1
Business Of Biotech

Matt Pillar

Unsubscribe
Unsubscribe
साप्ताहिक
 
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is p ...
  continue reading
 
Artwork

1
Biotech Career Coach

Carina Clingman

Unsubscribe
Unsubscribe
साप्ताहिक+
 
In the Biotech Career Coach podcast, we share valuable insights and advice for job seekers and career-minded individuals in the biotechnology and life sciences industry. From resume tips to leadership strategies, this podcast will help you navigate your job search and succeed in your career. This podcast is a production of The Collaboratory Career Hub To join our free Slack Community or access great free resources, visit www.collaboratorycareerhub.com
  continue reading
 
Artwork
 
Data in Biotech is a fortnightly podcast exploring how companies leverage data to drive innovation in life sciences. Every two weeks, Ross Katz, Principal and Data Science Lead at CorrDyn, sits down with an expert from the world of biotechnology to understand how they use data science to solve technical challenges, streamline operations, and further innovation in their business. You can learn more about CorrDyn - an enterprise data specialist that enables excellent companies to make smarter ...
  continue reading
 
Artwork

1
Building Biotechs

Recruitomics Consulting

Unsubscribe
Unsubscribe
साप्ताहिक
 
From the ground floor to the C-Suite, Building Biotechs offers a behind-the-scenes look into the strategy that goes into launching and scaling successful biotech and life science companies. We talk with biotech executives, founders, HR leaders, and culture builders to learn how they think about growing companies with intention, and discuss the valuable lessons they’ve learned along the way.
  continue reading
 
Welcome to the Biotech Bytes podcast, where we sit down with Biotech and Pharma IT leaders to learn what's working in our industry. Steven Swan is the CEO of The Swan Group LLC. He has 20 years of experience working with companies and individuals to make long-term matches. Focusing on Information technology within the Biotech and Pharmaceutical industries has allowed The Swan Group to become a valued partner to many companies. Staying in constant contact with the marketplace and its trends a ...
  continue reading
 
Artwork

1
Smart Biotech Scientist | Bioprocess CMC Development, Biologics Manufacturing & Scale-up for Busy Scientists

David Brühlmann: Biotech Entrepreneur & Cell Culture Technology Innovation Aficionado

Unsubscribe
Unsubscribe
साप्ताहिक+
 
The Go-to Podcast for Biotech Scientists Who Want to Master Bioprocess CMC Development and Manufacturing of Biologics. Do you want to simplify bioprocessing so that you can scale with confidence and reduce time to market? Are you sick of feeling overwhelmed by the complexity and guesswork of biologics drug development? Do you wish you had more time to enjoy the beauty of science, without worrying about failing your cell culture process development and commercialization? There’s a way to simp ...
  continue reading
 
DrugPatentWatch serves leading companies ranging from biopharmaceutical R&D to healthcare delivery, and has been cited by CNN, NEJM, Nature Journals, and many other leading publications. Use cases for the DrugPatentWatch platform include: - Branded pharmaceutical global business intelligence and forecasting - Generic drug and API manufacturer portfolio management - Wholesalers preventing overstock of off-patent drugs - Healthcare payer formulary management and budget management
  continue reading
 
Artwork
 
Talking Biotech is a weekly podcast that uncovers the stories, ideas and research of people at the frontier of biology and engineering. Each episode explores how science and technology will transform agriculture, protect the environment, and feed 10 billion people by 2050. Interviews are led by Dr. Kevin Folta, a professor of molecular biology and genomics.
  continue reading
 
Artwork

1
Biotech & Breweries

Daniel Schroeder

Unsubscribe
Unsubscribe
मासिक
 
San Diego has grown into one of the largest biotechnology hubs in the United States with some very talented people doing very exciting things. Come along with me as I explore the world of biotech, meet some interesting people, and maybe even learn a thing or two. Oh wait… did I mention there will be beer?
  continue reading
 
Horizon 3 is a biotech fund which has been formed to help investors to have a real impact on a range of global health challenges through new bio technologies, aiming to de-risk the investment risks inherent in such a technical area.These podcasts are a series aimed at educating investors on the issues, risks and opportunities involved in investing ion the biotech sector.
  continue reading
 
In einer Podcast Folge wird jeweils ein Punkt einer Lernplaneinheit vorgestellt. Viele sind One-Taker meiner eigenen Biotech-Abi Vorbereitung :D Cover art photo provided by Annie Spratt on Unsplash: https://unsplash.com/@anniespratt
  continue reading
 
Artwork

1
The Biotech Futurist

thebiotechfuturistpodcast

Unsubscribe
Unsubscribe
मासिक
 
The Biotech Futurist aims to foster deep understanding and discussion about exciting hot topics in biotech at the intersection with artificial intelligence and medicine, exploring CRISPR therapeutics, neuroscience, genetic diseases, interventional genomics, machine learning in biology, behavior, neuroscience, omics, cellular recording, liquid biopsy, oncology, longevity, and more. Your host Luca Fusar Bassini, PhD student at EPFL in Switzerland, interviews an expert guest every week.
  continue reading
 
Artwork

1
The Longevity Biotech Show

The Longevity Biotech Show

Unsubscribe
Unsubscribe
मासिक
 
A weekly live audience show featuring the people building and funding companies that are extending healthy human lifespan. Join us Thursdays on Clubhouse and check the show schedule on longevitybiotechshow.com Hosted by Nathan Cheng (founder @ Longevity Marketcap // Longevity List) and Robert Ziman (Cohen Lab).
  continue reading
 
Explore the world of cloning, protein folding, genome mapping, and more with the most important researchers in the field. Although the show is no longer in production at TWiT, you can enjoy episodes from the TWiT Archives.
  continue reading
 
Explore the world of cloning, protein folding, genome mapping, and more with the most important researchers in the field. Although the show is no longer in production at TWiT, you can enjoy episodes from the TWiT Archives.
  continue reading
 
A podcast to share the tools, tips, tricks and routines of the best biotech executives in the industry in order to help develop the next generation of biotech leaders and expedite the launch of new therapies and transform the lives of patients' all over the world.
  continue reading
 
Encode Ideas authors research on publicly traded micro / small cap healthcare (biotech & medtech) companies. The Plainspoken podcast is an extension of our research, where we will interview executives from micro / small cap health care companies, portfolio managers who invest in micro / small cap healthcare, and key opinion leaders who can offer insights into therapeutics areas of interest to investors. The podcast is for entertainment purposes only and should not be considered financial adv ...
  continue reading
 
Artwork
 
Interviews with the researchers, founders, and investors of the BioTech industry. An insiders look into what is going on in the world of BioTech, from curing aging to psychedelic therapy, we interview the game changers of the industry. The unsung hero's that are moving the industry forward in a significant way. The world is going to be a vastly different place in the next 10-20 years because of what's happening in the BioTech industry right now.Human civilization will move forward farther, f ...
  continue reading
 
Loading …
show series
 
In this episode of the Emerging Biotech Leader podcast, hosts Kim Kushner and Ramin Farhad are joined by Bob Honigberg to further discuss the considerable challenge of achieving bold missions in healthcare. Building on their discussion from Episode 28 where they interviewed Cleerly Health founder Dr. Jim Ninh, the episode provides useful perspectiv…
  continue reading
 
Episode Description: Ross McBee, co-founder and CSO of TomTex, takes us into the innovative world of biomaterials, showcasing his commitment to sustainability and eco-friendly solutions. By turning waste shrimp shells into versatile, biodegradable materials, McBee is not just proposing an alternative to traditional textiles but is pioneering a futu…
  continue reading
 
Tome Biosciences recently exited stealth mode with almost a quarter of a billion dollars in funding. The company has developed a new approach to gene editing, programmable genomic integration (PGI), which it says represents the final chapter in genomic medicines. We discussed the company’s formation and approach with the CEO and president of Tome, …
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Abingworth has invested in Trodelvy development in a deal with Gilead, where one of the investment firm's startups will work with Gilead to expand the cancer drug's label. Cure Ventures has backed a cell therapy startup c…
  continue reading
 
The impact of AI on data management, particularly in the realm of biotechnology, is undeniable. It has fundamentally transformed how we approach and utilize vast amounts of data in this field. Joining me is Elisabeth Schwartz, the IT Head at Phathom, to explore the crucial task of preparing data for AI applications and the hurdles we face in ensuri…
  continue reading
 
Discover the hurdles and breakthroughs in glycoengineering, including the high costs of activated sugars. Thomas Rexer, CTO of eversyn, a spin-off of the Max Planck Institute Magdeburg, unveils eversyn's multi-step biocatalysis process, designed to significantly drive down costs and make in vitro glycoengineering more accessible on a large scale. K…
  continue reading
 
This week's guest is Joseph Pearson, Global Product Manager of OmicSoft at QIAGEN, a global provider of sample-to-insight solutions that enable customers to gain valuable molecular insights. During this episode, we dive into OmicSoft, a powerful NGS analysis suite that can quickly explore and compare 500,000 curated omics samples from disease-relat…
  continue reading
 
This week, Dr. Daniel Bloomfield from Anthos Therapeutics discusses the prevalence and dangers of blood clots, particularly in patients with cancer. Dr. Bloomfield explains the difference between normal and abnormal blood clotting, the risks associated with blood clots in arteries and veins, and the challenges in balancing clot prevention with the …
  continue reading
 
Synopsis: On the Biotech2050 podcast, Tuyen Ong, CEO at Ring Therapeutics and CEO partner at flagship pioneering, shared his journey from a medical background to leading innovative gene therapy companies, highlighting the importance of cross-disciplinary expertise in driving biotech advancements. His insights into the gene therapy landscape and the…
  continue reading
 
As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards. Part 2 of 3. My guest for this week’s episode is Martin Brenner, CEO and CSO of iBio. iBio uses its AI drug discovery platform to tackle complex an…
  continue reading
 
Dr. Herman Weiss is the CEO and co-founder of Provation Life (provationlife.com), an Israeli nutraceutical startup that helps women suffering from hormonal imbalance to support their fertility, weight loss and general medical health. Avraham sat down with Herman in his home in Beit Shemesh to discuss the problem that Provation Life solves, getting …
  continue reading
 
Multimodal approaches to the delivery of radiologically active compounds have created a fertile environment to for players in the space to put on a precision medicine clinic, so to speak. What’s more, Radiopharmaceuticals create a unique business opportunity given the closely-related and necessary companion diagnostic arena. On today’s episode of t…
  continue reading
 
To learn more about SULA LABS visit https://www.sula-labs.com/ To learn more about BCLA’s events and consulting visit https://www.bc-la.org/द्वारा Katherine Merkling, Serena Gao, Daniel Arce, Gabriella Rubert, Carys Layton, Daniel Graves
  continue reading
 
This week, we have something for both sides of the table, whether you're interviewing for your next job or interviewing candidates for your next hire. Navigating the interview process can feel like a minefield. How do you follow up? When should you follow up? Have I been ghosted? And if you're interviewing candidates, you also have a lot to keep in…
  continue reading
 
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.UnitedHealth is facing an antitrust probe by the DOJ regarding potential anticompetitive effects. Despite challenges like high labor costs, UHS, a hospital operator, saw revenue growth in 2023. Veradigm is set to delist a…
  continue reading
 
This week, we sat down with Tania Philipp, Chief People Officer at Vor Bio. Vor’s mission is to cure blood cancers through cell and genome engineering. Tania shares insights from rapid growth, hiring for culture during a pandemic, and taking a company public while maintaining culture and transparency. Vor Bio | Cell & Genome Engineering Biotechnolo…
  continue reading
 
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Denali, a biotech company, received a $500 million investment after facing setbacks in a clinical trial for an ALS drug. Viking presented data suggesting their obesity drug could rival those from Eli Lilly and Novo Nordi…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.##Title: Pfizer announces new breakthrough in cancer treatmentPfizer recently announced a new breakthrough in cancer treatment. The new drug has shown promising results in clinical trials, with a higher success rate and f…
  continue reading
 
Get ready for a crash course in glycoengineering as Thomas Rexer, CTO of eversyn, a spin-off of the Max Planck Institute Magdeburg, breaks down the significance of modifying glycans in biopharmaceuticals. Explore the science behind glycoengineering and its potential to enhance the properties of therapeutic proteins. Key Insights: Unlock new frontie…
  continue reading
 
Switching pharmaceutical excipients, the inactive components used in drug formulations, can have significant implications for both production costs and market appeal. These components, while not contributing directly to the therapeutic…The post Cost-Cut Without Compromise: Navigating Excipient Switching in Pharma appeared first on DrugPatentWatch -…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.The biopharma industry is facing challenges with the rocky launch of Roctavian by Biomarin, as well as the departure of AbbVie CEO Richard Gonzalez. Frontier is making strides in developing a better KRAS drug with support…
  continue reading
 
Episode Description: Edward Shenderovich, a seasoned entrepreneur and visionary in the biomanufacturing space, takes us through his journey into the heart of biotechnology and its potential to reshape industries. Edward discusses the inception of Synonym and its mission to revolutionize biomanufacturing by creating a cloud infrastructure that accel…
  continue reading
 
After decades of lagging nearly many other disease areas, neurology is finally seeing signs of significant innovation. One of the biggest reasons it’s trailed behind has been the difficulty in teasing out complex neurobiology – an understanding necessary to design novel medicines. Rapport Therapeutics is playing a significant role in turning the ti…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. On February 22, 2024, significant developments in the biopharma industry were reported. Ori Capital raised a new biotech fund to support startups working on innovative drugmaking approaches. The Biden administration pled…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.##FDA Approves New Drug for Cancer TreatmentIn a groundbreaking move, the FDA has approved a new drug for the treatment of a rare form of cancer. This drug has shown promising results in clinical trials, with patients exp…
  continue reading
 
In our insightful second part of the conversation, we broaden our perspective to delve into the various modalities within the biotech industry, highlighting the unique and shared aspects of process development and scale-up. Neil Templeton, the Director of Upstream Process Development at Solid Biosciences, passionately articulates his commitment tow…
  continue reading
 
Dr. Lishan Aklog from Lucid Diagnostics tells us about the path from GERD to, unfortunately, esophageal cancer, and about Lucid’s two-minute diagnostic test which can detect precancerous cells.द्वारा Moira Gunn
  continue reading
 
Synopsis: In a recent episode of Biotech2050, hosted by Alok Tayi, Kristen Fortney, CEO of BioAge, provides valuable insights into the evolving landscape of aging biology and the innovative approach BioAge is taking to identify therapeutic targets. Kristen's background in aging biology, genetics, and statistics underscores her expertise in the fiel…
  continue reading
 
In this episode, we sat down with Dan Goddard of Browne Consulting, which specializes in accounting, finance, and human resources services to venture-backed Life Science start-ups and emerging companies. Dan is passionate about creating mission-driven companies, and he shares great insight into the cyclical nature of biotech and how founding and gr…
  continue reading
 
As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards. Part 1 of 3. My guest for this week’s episode is Martin Brenner, CEO and CSO of iBio. iBio uses its AI drug discovery platform to tackle complex an…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Analysts predict that GLP-1 drugs like Zepbound and Ozempic will be highly profitable, reshaping the pharmaceutical industry by treating obesity. Lilly's sales have soared due to demand for their obesity and diabetes drugs,…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Novo has licensed the potential first-in-class antibody candidate to Almirall, granting them exclusive global rights to develop and commercialize the anti-IL-21 monoclonal antibody NN-8828. The FDA's shift towards overall…
  continue reading
 
In this enlightening episode, we're joined by Neil Templeton, Director in Upstream Process Development at Solid Biosciences, who pulls back the curtain on the intricate world of bioprocess development and manufacturing. Neil delves into the shifting paradigms of the industry, sharing his expert insights on overcoming the unique challenges that surf…
  continue reading
 
While you might be aware that Sail Biomedicines was just formed up in Q4 of last year, the product of Flagship Pioneering’s decision to merge Senda Biosciences and Laronde, two of its programmable medicine platform companies. What you likely haven’t heard is the inside story on how the merger was executed, how the two companies are integrating thei…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.##FDA Approves New Cancer DrugThe FDA has approved a new drug for the treatment of a rare form of cancer. The drug has shown promising results in clinical trials and is expected to provide a new treatment option for patie…
  continue reading
 
Episode Description: Julia Marsh of Sway discusses the revolutionary potential of seaweed in addressing the pervasive issue of plastic pollution. With a focus on sustainable packaging solutions, Marsh highlights how Sway leverages the natural properties of seaweed to create compostable, eco-friendly alternatives to traditional plastic. Through a bl…
  continue reading
 
Artificial intelligence (AI) is certainly in the news constantly; however, it’s been used in drug discovery for some time. A new collaboration between artificial intelligence drug discovery company Insilico Medicine and University of Toronto biochemist and molecular geneticist Igor Stagljar will test AI-designed molecules against "undruggable" canc…
  continue reading
 
Good morning from Pharma and Biotech Daily, the podcast that gives you only what's important to hear in the Pharma and Biotech world. French drugmaker Sanofi has announced positive results from a Phase II trial of its experimental drug frexalimab in relapsing multiple sclerosis (MS). The trial, published in the New England Journal of Medicine, show…
  continue reading
 
Elevate your excipient business strategies with the comprehensive Drug Excipient Business Development Reports from DrugPatentWatch. Designed for excipient manufacturers seeking lucrative opportunities in the pharmaceutical industry, these reports offer invaluable…The post Drug Excipient Business Development Reports now Available on Amazon appeared …
  continue reading
 
The convergence of technology and business savvy is reshaping the biotech landscape. Today's leaders are adept at harnessing IT to drive profitability and impact lives, turning data and innovation into strategic gold. In this episode, I sit down with Eduard De Vries, a visionary at the intersection of IT and healthcare business strategy. Eduard sha…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Biogen is facing additional troubles as the Department of Justice (DOJ) and Securities and Exchange Commission (SEC) have issued subpoenas seeking more information. The DOJ is specifically looking into the company's overs…
  continue reading
 
Tackling bioprocess development and scale-up can be complex. While the science might be challenging, project management within biotech doesn't have to be. In this engaging episode, we'll guide you on how to streamline your CMC development, demystifying the complexities of project planning and execution. Here's what you'll gain: Discover the secret …
  continue reading
 
Dr. Eric Merle from GenoSkin talks about how they are transforming drug discovery using discarded human skin from surgeries like tummy tucks, revolutionizing the process and accelerating drug development timelines.द्वारा Moira Gunn
  continue reading
 
"I believe that we can eradicate heart attacks from this world...If we can leverage these tools to accomplish those three goals, whether it's in coronary heart disease, valvular heart disease, myocardial disease, et cetera, et cetera, I think that's going to not be a slight improvement. I think it's going to be a game changer in terms of improving …
  continue reading
 
This week's guest is Wolfgang Halter, Head of Data Science and Bioinformatics at Merck Life Science, a leading global science and technology company. Ross sat down with Wolfgang to discuss the work on the BayBE project, an open-source library built for Bayesian optimization. Throughout the episode, we go on to learn how BayBE is used for both exper…
  continue reading
 
Synopsis: In this episode of the Biotech2050 podcast, Chris Gibson, the co-founder and CEO of Recursion, shares insights on the intersection of technology and biotech, emphasizing the importance of adaptability and diverse partnerships in driving innovation. Gibson's journey from pursuing an MD-PhD program with a focus on merging engineering and me…
  continue reading
 
As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards. Part 3 of 3. My guest for this week’s episode is Jeff Kim, co-founder and CEO of Slingshot Biosciences. Slingshot designs and manufactures syntheti…
  continue reading
 
In this episode, we chatted with Stephanie Culler, PhD, Co-Founder and CEO of Persephone Biosciences and part of the Y Combinator 2018 cohort. Persephone is committed to delivering industry-leading technologies for the development of microbiome-targeted therapeutics. We talked about all things poop, as well as strategies to turn a passion for curin…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Today we have some exciting news to share with you.## The biotech industry is gaining momentum in 2024, with emerging companies and their investors adapting to industry changes. Biopharma Dive is offering a trendline tha…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.##News 1: New treatment for Alzheimer's diseaseIn a groundbreaking development, researchers have announced a new treatment for Alzheimer's disease. The drug, called ADX-100, has shown promising results in early clinical t…
  continue reading
 
Loading …

त्वरित संदर्भ मार्गदर्शिका